Summary
-
1.
Imipramine in small doses (0.5–1 mg/kg) intensified, but in large doses (60–100 mg,) reduced the toxic effects of amphetamine: motor excitation, agressivity, fighting and lethality in grouped albino mice.
The different influence of low and high doses of imipramine on the central effects of amphetamine suggests, that dual (positive and negative) action of imipramine on adrenergic synapses, previously observed on peripheral synapses, occurs also in the brain.
-
2.
Chlorpromazine, like imipramine, not only decreased (in doses of 2.5 and 5.0 mg/kg), but also increased (in doses of 0.005–0.01 mg/kg) amphetamine group toxicity. The latter effect may be termed, “paradoxical”.
-
3.
The similarity of both the tranquilizing and analeptic effects of imipramine and chlorpromazine suggests that the mediator natur and possibly the localization of action of two drugs are common.
-
4.
Amphetamine group toxicity may be applied as a sensitive test for evaluation of stimulant (psychoanaleptic) activity.
-
5.
A scheme of qualitative and quantitative relationships between the effects of imipramine and chlorpromazine over wide dose ranges is suggested.
Similar content being viewed by others
References
Brodie, B. B., F. Sulser, and E. Costa: Psychotherapeutic drugs. Ann. Rev. Med. 12, 349–368 (1961).
Burn, J. H., and R. Hobbs: A test for tranquillizing drugs. Arch. int. Pharmacodyn. 113, 290–297 (1958).
Carlton, P. L., and P. Didamo: Augmentation of the behavioral effects of amphetamine by atropine. J. Pharmacol. exp. Ther. 132, 91–96 (1961).
Chance, M. R. A.: Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice. J. Pharmacol. exp. Ther. 87, 214–219 (1946).
Chen, G., and B. Bohner: The anti-reserpine effects of certain centrally-acting agents. J. Pharmacol. exp. Ther. 131, 179–184 (1961).
Ditfurth, H. v.: Zur Frage des Wirkungsmechanismus pyschotroper Pharmaka, speziell des Tofranil. Med. exp. 2, 147–153 (1960).
Domenjoz, R., u. W. Theobald: Zur Pharmakologie des Tofranil (N-—Dimethylaminopropyl/-iminodibenzyl-hydrochlorid). Arch. int. Pharmacodyn. 120, 450–489 (1959).
Frommel, Ed., et C. Fleury: De l'influence «rajeunissante» de la procaine. Interprétation pharmacodynamique. Méd. et Hyg. 19, 52 (1961).
— —, et J. Schmidt-Ginzkey: De l'action psychoanaleptique du tofranil. J. suisse Med. 90, 830–832 (1960a).
— — —, et M. Béguin: De la pharmacodynamie différentielle thymoanaleptiques et de substances «neuroleptiques» en expérimentation animale. Thérapie 15, 1175–1198 (1960b).
Gillette, J. R., J. V. Dingell, F. Sulser, R. Kuntzman, and B. B. Brodie: Isolation from rat brain of a metabolic product, desmethylimipramine, that mediates the antidepressant activity of imipramine (tofranil). Experientia (Basel) 17, 417–418 (1961).
Greenblatt, E. N., and A. C. Osterberg: Correlations of activating and lethal effects of excitatory drugs in grouped and isolated mice. J. Pharmacol. exp. Ther. 131, 115–119 (1961).
Gunn, J. A., and M. R. Gurd: The action of some amines related to adrenaline. Cyclohexylalkylamines. J. Physiol. 97, 453–470 (1940). (Lond.).
Khruleva, L. N.: O vlianii aminazina na vyshuju nervnuju deiatelnost sobak (On the influence of aminazine on higher nervous activity in dogs). Zh. Nevropat. Psikhiat. 60, 577–584 (1960).
Lapin, I. P., R. A. Khaunina i E. L. Stchelkunov: Vlianie tofranila na effecti adrenalina, noradrenalina i phenamina (The influence of tofranil on effects of adrenaline, noradrenaline and phenamine). Zh. Nevropat. Psikhiat. 62, 183–189 (1962).
Lasagna, L., and W. P. McCann: Effect of “tranquilizing” drugs on amphetamine toxicity on aggregated mice. Science 125, 1241–1242 (1957).
Mashkovski, M. D., i. A. I. Polejaeva: K farmakologii imizina (tofranila) — novogo neirotropnogo veshestva (On pharmacology of imizin (tofranil) — a new neurotropic agent). Z. Nevropat. Psikhiat. 59, 964–971 (1959).
Maxwell, D. R.: The activity of some adrenaline antagonists in tests for tranquillizing action. In: Neuropsychopharmacology, ed. by P. B. Bradley, P. Deniker, C. Radouco-Thomas, pp. 365–373. Amsterdam: Elsevier Publ. Co. 1959.
Missere, G., e G. Tonini: Proprieta farmacologiche del cloridrato di N-(γ-dimetilaminopropil)iminodibenzile. Boll. Soc. ital. Biol. sper. 35, 1115–1117 (1959).
Monnier, M., u. P. Krupp: Elektrophysiologische Analyse der Wirkungen verschiedener Neuroleptica (Chlorpromazin, Reserpin, Tofranil, Meprobamat). Schweiz. med. Wschr. 89, 430–433 (1959).
Osborn, M., and E. B. Sigg: Effects of imipramine on the peripheral antonomic system. Arch. int. Pharmacodyn. 129, 273–289 (1960).
Penaloza-Rojas, J. H., G. Bachy-Rita, H. F. Rubio-Chevannier, and R. Hernandez-Peon: Effects of imipramine upon hypothalamic and amygdaloid excitability. Exp. Neurol. 4, 205–213 (1961).
Rubio-Chevannier, H., G. Bach-y-Rita, J. Penaloza-Rojas, and R. Hernandez-Peon: Potentiating action of imipramine upon “reticular arousal”. Exp. Neurol. 4, 214–220 (1961).
Sigg, E. B.: Pharmacological studies with tofranil. Canad. psychiat. Ass. J. 4, Spec. Suppl. 75–83 (1959).
Sikharulidze, A. I.: Nekotorie voprosi farmakologii tofranila (Some questions of pharmacology of tofranil). Soob. Akad. nauk Graz. SSR 26, 95–98 (1961).
Stein, L., and J. Seifter: Possible mode of antidepressive action of imipramine. Science 134, 286–287 (1961).
Sulser, F., and B. B. Brodie: On mechanism of the antidepressant action of imipramine (Abstr.) Biochem. Pharmacol. 8, 16 (1961).
-, and J. Watts: On the antireserpine actions of imipramine (tofranil). In: Techniques for the study of psychotropic drugs. Modena, Soc. tipogr. modenese, 1960, pp. 85–87.
— —, and B. B. Brodie: Antagonistic actions of imipramine (tofranil) and reserpine an central nervous system. Fed. Proc. 19, 268 (1960).
Swinyard, E. A., L. D. Clark, J. T. Miyahara, and H. H. Wolf: Studies on the mechanism of amphetamine toxicity in aggregated mice. J. Pharmacol. exp. Ther. 132, 97–102 (1961).
Witt, P. N.: Sensitivity to amphetamine in spiders after iproniazid and imipramine. J. Pharmacol. exp. Ther. 132, 183–192 (1961).
Zetler, G.: Pharmakologische Eigenschaften antidepressiv wirkender Pharmaka. Dtsch. med. Wschr. 52, 2276–2281 (1960).
Zuanazzi, G. R., et F. Rognoni: Il G 22355, nuovo derivato ad azione timolettica: proprietá farmacologiche. Atti Soc. lombarda Sci. med.-biol. 14, 305–310 (1959).
Author information
Authors and Affiliations
Additional information
Reported at the Symposium on the Research of Influence of Psychotropic Drugs on Higher Nervous Activity, Prague, October 31st–November 3rd 1961.
Rights and permissions
About this article
Cite this article
Lapin, I.P. Qualitative and quantitative relationships between the effects of imipramine and Chlorpromazine on amphetamine group toxicity. Psychopharmacologia 3, 413–422 (1962). https://doi.org/10.1007/BF00411158
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00411158